The expression of 8-hydroxydeoxyguanosine in oesophageal tissues and tumours

European Journal of Surgical Oncology

Volumn 33, Issue 10, 2007, Pages 1164-1168

  Rasanen J V ^a   Sihvo, E I T ^a   Ahotupa, M O ^b   Farkkila M A ^a   Salo, J A ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

8 OH deoxyguanosine; Adenocarcinoma of oesophagus and oesophagogastric junction; Barrett's oesophagus; Oxidative damage

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; DNA;

ADULT; ARTICLE; BARRETT ESOPHAGUS; CARCINOGENESIS; CONTROLLED STUDY; DNA DAMAGE; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS MUCOSA; FEMALE; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; OXIDATIVE STRESS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; BIOPSY; DEOXYGUANOSINE; DNA DAMAGE; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; ESOPHAGOSCOPY; ESOPHAGUS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; OXIDATIVE STRESS;

EID: 36048949665     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2007.03.003     Document Type: Article

References (32)

1. Pera M., Cameron A.J., Trastek V.F., Carpenter H.A., and Zinsmeister A.R. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 104 (1993) 510-513
2. Devesa S.S., Blot W.J., and Fraumeni Jr. J.F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83 (1998) 2049-2053
3. Sihvo E.I.T., Salminen J.T., Ramo O.J., and Salo J.A. The epidemiology of oesophageal adenocarcinoma: has the cancer of gastric cardia an influence on the rising incidence of oesophageal adenocarcinoma?. Scand J Gastroenterol 10 (2000) 1082-1086
4. Lagergren J., Bergstrom R., Lindgren A., and Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340 (1999) 825-831
5. Oh T.Y., Lee J.S., Ahn B.O., et al. Oxidative stress is more important than acid in the pathogenesis of reflux oesophagitis in rats. Gut 49 (2001) 364-371
6. Olyaee M., Sontag S., Salman W., et al. Mucosal reactive oxygen species production in oesophagitis and Barrett's oesophagus. Gut 37 (1995) 168-173
7. Sihvo E.I., Salminen J.T., Rantanen T.K., et al. Oxidative stress has a role in malignant transformation in Barrett's oesophagus. Int J Cancer 102 (2002) 551-555
8. Lee J.S., Oh T.Y., Ahn B.O., et al. Involvement of oxidative stress in experimentally induced reflux esophagitis and Barrett's esophagus: clue for the chemoprevention of esophageal carcinoma by antioxidants. Mutat Res 480-481 (2001) 189-200
9. Kuchino Y., Mori F., Kasai H., et al. Misreading of DNA templates containing 8-hydroxydeoxyguanosine at the modified base and at adjacent residues. Nature 327 (1987) 77-79
10. Hussain S.P., and Harris C.C. Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. Cancer Res 58 (1998) 4023-4037
11. Sgambato A., Zannoni G.F., Faraglia B., et al. Decreased expression of the CDK inhibitor p27Kip 1 and increased oxidative DNA damage in the multistep process of cervical carcinogenesis. Gynecol Oncol 92 (2004) 776-783
12. Gottschling B.C., Maronpot R.R., Hailey J.R., et al. The role of oxidative stress in indium phosphide-induced lung carcinogenesis in rats. Toxicol Sci 64 (2001) 28-40
13. Karim M.R., Wanibuchi H., Wei M., Morimura K., Salim E.I., and Fukushima S. Enhancing risk of ethanol on MeIQx-induced rat hepatocarcinogenesis is accompanied with increased levels of cellular proliferation and oxidative stress. Cancer Lett 192 (2003) 37-47
14. Brown N.S., and Bicknell R. Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res 3 (2001) 323-327
15. Younes M., Lechago J., Chakraborty S., et al. Relationship between dysplasia, p53 protein accumulation, DNA ploidy, and Glut1 overexpression in Barrett metaplasia. Scand J Gastroenterol 35 (2000) 131-137
16. Carlson N., Lechago J., Richter J., et al. Acid suppression therapy may not alter malignant progression in Barrett's metaplasia showing p53 protein accumulation. Am J Gastroenterol 97 (2002) 1340-1345
17. Chen X., Ding Y.W., Yang G., Bondoc F., Lee M.J., and Yang C.S. Oxidative damage in an esophageal adenocarcinoma model with rats. Carcinogenesis 21 (2000) 257-263
18. Jankowski J.A., Harrison R.F., Perry I., Balkwill F., and Tselepis C. Barrett's metaplasia. Lancet 356 (2000) 2079-2085
19. Terry P., Lagergren J., Ye W., Nyren O., and Wolk A. Antioxidants and cancers of the esophagus and gastric cardia. Int J Cancer 87 (2000) 750-754
20. Oh T.Y., Lee J.S., Ahn B.O., et al. Oxidative damages are critical in pathogenesis of reflux esophagitis: implication of antioxidants in its treatment. Free Radic Biol Med 30 (2001) 905-915
21. Kasai H., and Nishimura S. Hydroxylation of guanine in nucleosides and DNA at the C-8 position by heated glucose and oxygen radical-forming agents. Environ Health Perspect 67 (1986) 111-116
22. Olliver J.R., Hardie L.J., Dexter S., Chalmers D., and Wild C.P. DNA damage levels are raised in Barrett's oesophageal mucosa relative to the squamous epithelium of the oesophagus. Biomarkers 8 (2003) 509-521
23. Salminen J.T., Ramo O.J., Ahotupa M.O., Farkkila M.A., and Salo J.A. Increased DNA adducts in Barrett's esophagus and reflux-related esophageal malignancies. Ann Med 34 (2002) 565-570
24. Kawamura O., Aslam M., Rittmann T., Hofmann C., and Shaker R. Physical and pH properties of gastroesophagopharyngeal refluxate: a 24-hour simultaneous impedance ambulatory and pH monitoring study. Am J Gastroenterol 99 (2004) 1000-1010
25. Wetscher G.J., Hinder R.A., Bagchi D., et al. Reflux esophagitis in humans is mediated by oxygen-derived free radicals. Am J Surg 170 (1995) 552-556
26. Bonde P., Gao D., Chen L., et al. Duodenal reflux leads to down regulation of DNA mismatch repair pathway in an animal model of esophageal cancer. Ann Thorac Surg 83 (2007) 433-440
27. Olliver J.R., Hardie L.J., Gong Y., et al. Risk factors, DNA damage, and disease progression in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 14 (2005) 620-625
28. Collins A.R., Dusinska M., Gedik C.M., and Stetina R. Oxidative damage to DNA: do we have a reliable biomarker?. Environ Health Perspect 104 Suppl. 3 (1996) 465-469
29. Sun Y. Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic Biol Med 8 (1990) 583-599
30. Oberg S., Peters J.H., DeMeester T.R., et al. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg 226 (1997) 522-530 discussion 530-532
31. Rantanen T.K., Rasanen J.V., Sihvo E.I.T., Ahotupa M.O., Färkkilä M.A., and Salo J.A. The impact of antireflux surgery on oxidative stress of esophageal mucosa caused by gastroesophageal reflux disease: A four-year follow-up study. Am J Gastroenterol 101 (2006) 222-228
32. Chevillard S., Radicella J.P., Levalois C., et al. Mutations in OGG1, a gene involved in the repair of oxidative DNA damage, are found in human lung and kidney tumours. Oncogene 16 (1998) 3083-3086